CD34-selected allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in the tyrosine kinase era Research Letter

  

Authors:	Vaughn, J. L.; Brown, S.; Papadopoulos, E. B.; Jakubowski, A. A.; Tamari, R.; Giralt, S. A.; Ponce, D. M.; Cho, C.; Perales, M. A.; Shaffer, B. C.; Gyurkocza, B.
Title:	CD34-selected allogeneic hematopoietic cell transplantation for chronic myeloid leukemia in the tyrosine kinase era
Keywords:	adult; cancer survival; clinical article; controlled study; overall survival; outcome assessment; follow up; letter; cd34 antigen; protein kinase inhibitor; hematopoietic stem cell transplantation; protein tyrosine kinase; chronic myeloid leukemia; retrospective study; cancer mortality; protein kinase inhibitors; acute graft versus host disease; chronic graft versus host disease; graft versus host reaction; allogeneic hematopoietic stem cell transplantation; protein-tyrosine kinases; leukemia relapse; leukemia, myelogenous, chronic, bcr-abl positive; antigens, cd34; cd34 selection; log rank test; humans; human
Journal Title:	Bone Marrow Transplantation
Volume:	57
Issue:	11
ISSN:	0268-3369
Publisher:	Nature Publishing Group
Date Published:	2022-11-01
Start Page:	1740
End Page:	1742
Language:	English
DOI:	10.1038/s41409-022-01783-7
PUBMED:	36076011
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85137496461&doi=10.1038%2fs41409-022-01783-7&partnerID=40&md5=c16ccd8a3af52b64d3c8125b89ffce15
Notes:	Letter -- Export Date: 1 December 2022 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/200612